Brother Undergoes Risky Procedure to Help Lymphoma-Stricken Sister

A South Florida man agreed to have surgery in order to save his sister from a deadly form of lymphoma, NBC is reporting.

Michael Torres, in an effort to aid his 53-year-old sister, Ana, who had battled lymphoma for a number of years, agreed to a very risky stem cell transplant procedure.

"All along, I knew I was going to be fine. I just knew I was," said Ana Torres when speaking to reporters.

"He was a match, and I was like, I can't begin to tell you."

According to doctors, the procedure -- which would be extremely dangerous for anyone -- was particularly risky for Michael, who weighed in at almost 450 pounds. Despite being told by doctors that he would need to lose the weight in a hurry, Michael was committed to helping his sibling.

Following a gastric bypass surgery, Michael cannot help but to be taken aback by the change.

"I look at myself and I say, 'Oh my God,' but I know that I've lost because I wasn't able to sleep four hours before. I wasn't able to touch my hair. It would have been impossible," he said.

Ana Torres understands that it may take her brother a while to get to his necessary weight goal, but she’s maintained her trademark calm and cool.

"I said, 'Brother, you come first. You got your surgery done. Everything will come, like I said. Everything has its time. Everything has its place,'" she told reporters.

Doctors expected Michael to lose up to 150 pounds over the course of the next three months.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap